Aktis Oncology, Inc. (AKTS) vs MeiraGTx Holdings PLC (MGTX)
Aktis Oncology, Inc. and MeiraGTx Holdings PLC are both Biotechnology companies. Aktis Oncology, Inc. and MeiraGTx Holdings PLC are of similar size ($1.1B and $1.1B). Aktis Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; MeiraGTx Holdings PLC trades at 14.4×. MeiraGTx Holdings PLC has the higher net margin (19.9% vs −782.0%) and the higher return on invested capital (66.6% vs 0.00%). Across the 16 metrics below, MeiraGTx Holdings PLC leads on 12 and Aktis Oncology, Inc. on 4.
Valuation
Profitability
| Metric | AKTS | MGTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 97.95% | 65.16% |
| Operating margin | (939.13%) | 46.30% | 0.00% |
| Net margin | (781.95%) | 19.87% | 0.00% |
| Free cash flow margin | (1,442.91%) | 2.55% | 0.00% |
| Return on equity | (34.45%) | 72.22% | (57.72%) |
| Return on assets | (27.09%) | 26.54% | (49.22%) |
| Return on invested capital | 0.00% | 66.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack